Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Acadia Healthcare Company
ACHC
Acadia Healthcare Company
Increasing Mental Health Awareness And Industry Consolidation Will Drive Transformation
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
26 Jul 25
Updated
21 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$49.43
54.6% undervalued
intrinsic discount
21 Aug
US$22.44
Loading
1Y
-71.4%
7D
6.2%
Author's Valuation
US$49.4
54.6% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$49.4
54.6% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-211m
4b
2014
2017
2020
2023
2025
2026
2028
Revenue US$4.2b
Earnings US$363.6m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
7.49%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.46%
Calculation
US$363.62m
Earnings '28
x
15.21x
PE Ratio '28
=
US$5.53b
Market Cap '28
US$5.53b
Market Cap '28
/
90.75m
No. shares '28
=
US$60.94
Share Price '28
US$60.94
Share Price '28
Discounted to 2025 @ 7.52% p.a.
=
US$49.02
Fair Value '25